Skip to main content
SpringerLink
Log in

PCOS: Implications of Cardiometabolic Dysfunction

  • Chapter
  • First Online:
Pre-Menopause, Menopause and Beyond

Part of the book series: ISGE Series ((ISGE))

  • 1239 Accesses

Abstract

Polycystic ovary syndrome (PCOS) represents the most common endocrine disorder in women of reproductive age with a reported incidence of 6–15%, depending on the criteria used for defining this heterogeneous condition [1–4]. According to the Rotterdam criteria, at least two of the three following features must be present: ovulatory dysfunction, clinical or biochemical hyperandrogenism and polycystic ovarian morphology [2, 3]. Other possible underlying pathologies must be excluded. Familial clustering of this heterogeneous condition has clearly been shown although the aetiology and the genetic determinants of PCOS remain uncertain [5–7]. Needs for medical intervention in women with PCOS vary significantly depending on the stage of life (Fig. 10.1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ (2010) The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 25(2):544–551

    Article  PubMed  Google Scholar 

  2. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004a) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81(1):19–25

    Article  Google Scholar 

  3. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group (2004b) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19(1):41–47

    Article  Google Scholar 

  4. Williams DM, Palaniswamy S, Sebert S, Buxton JL, Blakemore AI, Hypponen E, Jarvelin MR (2016) 25-Hydroxyvitamin D concentration and leukocyte telomere length in young adults: findings from the northern finland birth cohort 1966. Am J Epidemiol 183:191–198

    Article  PubMed  PubMed Central  Google Scholar 

  5. Legro RS, Kunselman AR, Demers L, Wang SC, Bentley-Lewis R, Dunaif A (2002) Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome. J Clin Endocrinol Metab (87):2134–2138

    Google Scholar 

  6. Legro RS, Spielman R, Urbanek M, Driscoll D, Strauss JF 3rd, Dunaif A (1998) Phenotype and genotype in polycystic ovary syndrome. Recent Prog Horm Res 53:217–256

    CAS  PubMed  Google Scholar 

  7. Urbanek M, Legro RS, Driscoll DA, Azziz R, Ehrmann DA, Norman RJ, Strauss JF 3rd, Spielman RS, Dunaif A (1999) Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc Natl Acad Sci U S A 96:8573–8578

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, Carmina E, Chang J, Yildiz BO, Laven JS, Boivin J, Petraglia F, Wijeyeratne CN, Norman RJ, Dunaif A, Franks S, Wild RA, Dumesic D, Barnhart K (2012) Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril 97:28–38.e25

    Article  PubMed  Google Scholar 

  9. Wild RA, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale HF, Futterweit W, Lobo R, Norman RJ, Talbott E, Dumesic DA (2010) Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab 95(5):2038–2049

    Article  CAS  PubMed  Google Scholar 

  10. Broekmans FJ, Knauff EA, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BC (2006) PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG 113(10):1210–1217

    Article  CAS  PubMed  Google Scholar 

  11. Goverde AJ, van Koert AJ, Eijkemans MJ, Knauff EA, Westerveld HE, Fauser BC, Broekmans FJ (2009) Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria. Hum Reprod 24(3):710–717

    Article  CAS  PubMed  Google Scholar 

  12. Legro RS, Castracane VD, Kauffman RP (2004) Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv 59(2):141–154

    Article  PubMed  Google Scholar 

  13. Moran LJ, Misso ML, Wild RA, Norman RJ (2010) Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 16(4):347–363

    Article  CAS  PubMed  Google Scholar 

  14. Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, Macklon NS (2006) A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 12:673–683

    Article  CAS  PubMed  Google Scholar 

  15. Hart R, Norman R (2006) Polycystic ovarian syndrome—prognosis and outcomes. Best Pract Res Clin Obstet Gynaecol 20(5):751–778

    Article  PubMed  Google Scholar 

  16. de Wilde MA, Veltman-Verhulst SM, Goverde AJ, Lambalk CB, Laven JS, Franx A, Koster MP, Eijkemans MJ, Fauser BC (2014) Preconception predictors of gestational diabetes: a multicentre prospective cohort study on the predominant complication of pregnancy in polycystic ovary syndrome. Hum Reprod, 29:1327–1336

    Google Scholar 

  17. Palomba S, de Wilde MA, Falbo A, Koster MP, La Sala GB, Fauser BC (2015) Pregnancy complications in women with polycystic ovary syndrome. Hum Reprod Update 21:575–592

    Article  PubMed  Google Scholar 

  18. Mutlu B, Tigen K, Gurel E, Ozben B, Karaahmet T, Basaran Y (2011) The predictive value of flow-mediated dilation and carotid artery intima-media thickness for occult coronary artery disease. Echocardiography (Mount Kisco, NY) 28(10):1141–1147

    Article  Google Scholar 

  19. Sprung VS, Atkinson G, Cuthbertson DJ, Pugh CJ, Aziz N, Green DJ, Cable NT, Jones H (2013) Endothelial function measured using flow-mediated dilation in polycystic ovary syndrome: a meta-analysis of the observational studies. Clin Endocrinol 78(3):438–446

    Article  Google Scholar 

  20. Kaya MG, Yildirim S, Calapkorur B, Akpek M, Unluhizarci K, Kelestimur F (2015) Metformin improves endothelial function and carotid intima media thickness in patients with PCOS. Gynecol Endocrinol 31(5):401–405

    Article  CAS  PubMed  Google Scholar 

  21. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M (2007) Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115(4):459–467

    Article  PubMed  Google Scholar 

  22. Meyer ML, Malek AM, Wild RA, Korytkowski MT, Talbott EO (2012) Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 18(2):112–126

    Article  PubMed  Google Scholar 

  23. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R (1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15(4):827–832

    Article  CAS  PubMed  Google Scholar 

  24. Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, Liu K, Shea S, Szklo M, Bluemke DA, O’Leary DH, Tracy R, Watson K, Wong ND, Kronmal RA (2008) Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 358(13):1336–1345

    Article  CAS  PubMed  Google Scholar 

  25. Raggi P, Gongora MC, Gopal A, Callister TQ, Budoff M, Shaw LJ (2008) Coronary artery calcium to predict all-cause mortality in elderly men and women. J Am Coll Cardiol 52(1):17–23

    Article  PubMed  Google Scholar 

  26. Talbott EO, Zborowski JV, Rager JR, Boudreaux MY, Edmundowicz DA, Guzick DS (2004) Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome. J Clin Endocrinol Metab 89(11):5454–5461

    Article  CAS  PubMed  Google Scholar 

  27. Shroff R, Kerchner A, Maifeld M, Van Beek EJ, Jagasia D, Dokras A (2007) Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis. J Clin Endocrinol Metab 92(12):4609–4614

    Article  CAS  PubMed  Google Scholar 

  28. Talbott EO, Zborowski J, Rager J, Stragand JR (2008) Is there an independent effect of polycystic ovary syndrome (PCOS) and menopause on the prevalence of subclinical atherosclerosis in middle aged women? Vasc Health Risk Manag 4(2):453–462

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Pierpoint T, McKeigue PM, Isaacs AJ, Wild SH, Jacobs HS (1998) Mortality of women with polycystic ovary syndrome at long-term follow-up. J Clin Epidemiol 51(7):581–586

    Article  CAS  PubMed  Google Scholar 

  30. Wild S, Pierpoint T, Jacobs H, McKeigue P (2000) Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study. Hum Fertil (Camb) 3(2):101–105

    Article  Google Scholar 

  31. Elting MW, Korsen TJ, Bezemer PD, Schoemaker J (2001) Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population. Hum Reprod 16(3):556–560

    Article  CAS  PubMed  Google Scholar 

  32. Hart R, Doherty DA (2015) The potential implications of a PCOS diagnosis on a woman’s long-term health using data linkage. J Clin Endocrinol Metab 100(3):911–919

    Article  CAS  PubMed  Google Scholar 

  33. Dahlgren E, Janson PO, Johansson S, Lapidus L, Oden A (1992) Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women. Acta Obstet Gynecol Scand 71(8):599–604

    Article  CAS  PubMed  Google Scholar 

  34. Schmidt J, Landin-Wilhelmsen K, Brannstrom M, Dahlgren E (2011) Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study. J Clin Endocrinol Metab 96(12):3794–3803

    Article  CAS  PubMed  Google Scholar 

  35. Krentz AJ, von Muhlen D, Barrett-Connor E (2007) Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose-effect association with prevalent cardiovascular disease. Menopause (New York, NY) 14(2):284–292

    Article  Google Scholar 

  36. Khatibi A, Agardh CD, Shakir YA, Nerbrand C, Nyberg P, Lidfeldt J, Samsioe G (2007) Could androgens protect middle-aged women from cardiovascular events? A population-based study of Swedish women: The Women’s Health in the Lund Area (WHILA) Study. Climacteric 10(5):386–392

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Reproductive Medicine and Gynaecology, University Medical Center, Utrecht, The Netherlands

    Bart C. J. M. Fauser

Authors
  1. Bart C. J. M. Fauser
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bart C. J. M. Fauser .

Editor information

Editors and Affiliations

  1. Professor emeritus for Gynaecological Endocrinology and Reproductive Medicine, University of Bern, Bern, Switzerland

    Martin Birkhaeuser

  2. International Society of Gynecological Endocrinology, Pisa, Italy

    Andrea R. Genazzani

Rights and permissions

Reprints and permissions

Copyright information

© 2018 International Society of Gynecological Endocrinology

About this chapter

Cite this chapter

Fauser, B.C.J.M. (2018). PCOS: Implications of Cardiometabolic Dysfunction. In: Birkhaeuser, M., Genazzani, A. (eds) Pre-Menopause, Menopause and Beyond. ISGE Series. Springer, Cham. https://doi.org/10.1007/978-3-319-63540-8_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-63540-8_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-63539-2

  • Online ISBN: 978-3-319-63540-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation